X4 Pharmaceuticals (XFOR) Change in Receivables (2020 - 2025)
X4 Pharmaceuticals' (XFOR) quarterly Change in Receivables came in at -$318000.0 in Q4 2025, down 129.72% YoY from $1.1 million in Q4 2024, and down 25.2% on a QoQ basis from -$254000.0 in Q3 2025.
X4 Pharmaceuticals (XFOR) Change in Receivables (2020 - 2025) Analysis & Trends
X4 Pharmaceuticals (XFOR) has 3 years of Change in Receivables data on file, last reported at -$318000.0 in Q4 2025.
- Quarterly Change in Receivables fell 129.72% year-over-year to -$318000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$497000.0 (down 146.45% YoY) and the FY2025 annual result came in at -$497000.0, down 146.45% from the prior year.
- Change in Receivables retreated to -$318000.0 in Q4 2025, from -$254000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.1 million in Q4 2024 to a low of -$561000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | X4 Pharmaceuticals | 533.17 Mn | 338.08 Mn | 7.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -318,000.00 |
| Dec 31, 2025 | -318,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Jun 30, 2025 | 636,000.00 |
| Jun 30, 2025 | 636,000.00 |
| Mar 31, 2025 | -561,000.00 |
| Mar 31, 2025 | -561,000.00 |
| Dec 31, 2024 | 1.07 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Mar 31, 2020 | 3.00 Mn |
| Mar 31, 2020 | 3.00 Mn |